UK Expects 10 M Vaccine Doses in 2020

The United Kingdom expects to receive about 10 million doses of the newly-developed Pfizer and BioNTech vaccine for COVID-19 by the end of the year, Reuters reported.

The spokesman of the British Prime Minister Boris Johnson announced on Monday that the deal is pending regulatory approvals.

Pharmaceutical giant Pfizer has said that its COVID-19 vaccine study has shown that it prevents 90% of infections among those who had no evidence of previous infection. The company has been developing a vaccine with Germany’s BioNTech.

No fewer than 43,500 have been participating in the Phase 3 trial.

Pfizer Chairman Albert Bourla said it is a “great day for science and humanity” and will apply for emergency approval to use the vaccine by the end of November.

Based on current projections, Pfizer and BioNTech expect to produce up to 50 million doses of vaccine in 2020, and up to 1.3 billion doses in 2021.